Bridgeway Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,600	Closed	-$1.87M	–	1411
2023 Q2	$1.87M	Hold	2,600	–	–	0.04%	571
2023 Q1	$2.14M	Sell	2,600 -2,700	-51%	-$2.04M	0.06%	504
2022 Q4	$3.82M	Sell	5,300 -5,000	-49%	-$3.69M	0.1%	343
2022 Q3	$7.09M	Sell	10,300 -5,800	-36%	-$3.65M	0.19%	163
2022 Q2	$9.52M	Buy	16,100 +2,600	+19%	+$1.69M	0.22%	138
2022 Q1	$9.43M	Buy	+13,500	New	+$8.54M	0.18%	184
2021 Q1	–	Sell	-3,840	Closed	-$1.85M	–	1397
2020 Q4	$1.85M	Sell	3,840 -40	-1%	-$21.6K	0.04%	550
2020 Q3	$2.17M	Sell	3,880 -37,020	-91%	-$22.4M	0.05%	394
2020 Q2	$25.5M	Buy	+40,900	New	+$23.2M	0.52%	72
2016 Q1	–	Sell	-11,200	Closed	-$6.08M	–	1475
2015 Q4	$6.08M	Sell	11,200 -5,400	-33%	-$2.93M	0.11%	180
2015 Q3	$7.72M	Hold	16,600	–	–	0.16%	157
2015 Q2	$8.47M	Hold	16,600	–	–	0.17%	146
2015 Q1	$7.5M	Hold	16,600	–	–	0.15%	148
2014 Q4	$6.81M	Hold	16,600	–	–	0.16%	147
2014 Q3	$5.99M	Hold	16,600	–	–	0.15%	162
2014 Q2	$4.69M	Sell	16,600 -3,000	-15%	-$889K	0.12%	206
2014 Q1	$5.88M	Hold	19,600	–	–	0.17%	126
2013 Q4	$5.39M	Hold	19,600	–	–	0.16%	125
2013 Q3	$6.13M	Hold	19,600	–	–	0.21%	81
2013 Q2	$4.41M	Buy	+19,600	New	+$4.56M	0.18%	101